APA (7th ed.) Citation

S, P., H, B., MA, F., DZ, B., LR, D. A., S, G., . . . GW, S. (2020). A therapeutic HIV-1 vaccine reduces markers of systemic immune activation and latent infection in patients under highly active antiretroviral therapy. Vaccine, 38(27), 4336. https://doi.org/10.1016/j.vaccine.2020.04.015

Chicago Style (17th ed.) Citation

S, Pallikkuth, et al. "A Therapeutic HIV-1 Vaccine Reduces Markers of Systemic Immune Activation and Latent Infection in Patients Under Highly Active Antiretroviral Therapy." Vaccine 38, no. 27 (2020): 4336. https://doi.org/10.1016/j.vaccine.2020.04.015.

MLA (9th ed.) Citation

S, Pallikkuth, et al. "A Therapeutic HIV-1 Vaccine Reduces Markers of Systemic Immune Activation and Latent Infection in Patients Under Highly Active Antiretroviral Therapy." Vaccine, vol. 38, no. 27, 2020, p. 4336, https://doi.org/10.1016/j.vaccine.2020.04.015.